Tri-aryl/heteroaromatic cannabinoids and use thereof
US7888365B2 · kind B2 · utility
0Cited by
6References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2008 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Mar 3, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cannabinoid derivatives according to formula (I) are disclosedwherein, X, Y, R1, R2, and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.